• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Coronavirus
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
IVIG
Immunization
Immuno-oncology
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

May 11, 2017

Trending News Today: Aetna to Completely Withdraw from ACA Exchanges, Citing Financial Losses

Author(s):

Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

International health experts have questioned the efficacy of arthroscopic surgery, a common orthopedic procedure for patients with degenerative knee problems, according to Kaiser Health News. The investigators used 13 studies that included nearly 1700 patients, which showed that the surgery did not improve function or provide lasting pain relief. According to the experts, fewer than 15% of patients experienced improvement in pain and function 3 months after the procedure. Additionally, the beneficial effects went away after 1 year. The surgery can also expose patients to “rare but important harms,” such as infection, KHN reported. The panel’s recommendations counter previous guidelines from multiple medical groups that promote the procedure to patients with issues such as meniscal tears.

Aetna has announced that it will withdraw from all Affordable Care Act (ACA) insurance exchanges by 2018, reported The Washington Post. The company has cited significant financial losses and uncertainty surrounding the insurance marketplaces as a cause for their exit. Last year, Aetna lost $450 million on nearly 1 million of its customers with individual health policies on and off the insurance exchanges. Aetna spokesman TJ Crawford, said the insurance giant projects to lose another $200 million for 2017 on its remaining 255,000 ACA customers, the Post reported.

The brain disorder hereditary cerebral cavernous malformations—–characterized by irregular dilated capillaries that protrude from veins in the brain, and can leak blood or burst at any time––is caused by a specific type of bacteria that resides in the gut. The study is among the first to suggest that the bacteria may initiate the disease in seemingly unrelated organs, according to the New York Times. The investigators identified gram-negative bacteria, which carries lipopolysaccharides in the cell walls, as the cause of the brain disorder. Using mice, the investigators found that mice who developed abscesses developed the brain defect. Whereas, mice administered antibiotics that kill this common bacterium were completely protected from the brain defect. Although the findings are convincing, the authors warned that it is still too soon to determine whether antibiotics followed by a fecal transplant would work.

Related Videos
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Advertisement
Newborn baby -- Image credit: kieferpix | stock.adobe.com
May 8th 2025

INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Pharmacy students in a fellowship -- Image credit: Seventyfour | stock.adobe.com
May 5th 2025

Transformative Pharmacy Fellowships Can Shape Future Leaders

Mike Hennessy Jr, President and CEO
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Hepatitis B therapeutic vaccine -- Image credit: syhin_stas | stock.adobe.com
May 3rd 2025

Ferritin-NP-preS1 Therapeutic Vaccine With siRNA Shows Durable Effects in CHB

Gillian McGovern, Associate Editor
Results From ADVANCE-CIDP Trial Show IVIG 10% Effectively Treats CIDP Relapse
May 2nd 2025

Results From ADVANCE-CIDP Trial Show IVIG 10% Effectively Treats CIDP Relapse

Aislinn Antrim, Managing Editor
Related Content
Advertisement
Newborn baby -- Image credit: kieferpix | stock.adobe.com
May 8th 2025

INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Pharmacy students in a fellowship -- Image credit: Seventyfour | stock.adobe.com
May 5th 2025

Transformative Pharmacy Fellowships Can Shape Future Leaders

Mike Hennessy Jr, President and CEO
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Hepatitis B therapeutic vaccine -- Image credit: syhin_stas | stock.adobe.com
May 3rd 2025

Ferritin-NP-preS1 Therapeutic Vaccine With siRNA Shows Durable Effects in CHB

Gillian McGovern, Associate Editor
Results From ADVANCE-CIDP Trial Show IVIG 10% Effectively Treats CIDP Relapse
May 2nd 2025

Results From ADVANCE-CIDP Trial Show IVIG 10% Effectively Treats CIDP Relapse

Aislinn Antrim, Managing Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.